Treatment

Indications

• Fibroadenomas < 2 cm in size

• Asymptomatic adolescent patients

Measures: routine clinical breast exams (CBE) and age-appropriate imaging for a palpable breast mass

• Lesions diagnosed as fibroadenoma on imaging alone: Short-term (every 6 months for 2 years) follow-up with imaging is recommended.

• Biopsy-proven fibroadenomas: Longer surveillance intervals may be considered.

Large size (e.g., > 2 cm) or rapid growth

Suspected malignancy

Bothersome symptoms or cosmetic concerns

Generally good

Most fibroadenomas are not associated with an increased risk of breast cancer.